Despite current strategies to treat HIV infection and its complications, Pneumocystis (PC) pneumonia remains a common clinical problem (Morris et al., 2004) thus there is a need to develop CD4+ T cell–independent therapeutic strategies to prevent this infection. This evidence concerns the gene CD4 and infection.